Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ihm, Sang-Hyun
NCT05878561: A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy	Completed	3	248	RoW	Fimasartan + Indapamide, I : BR1015-3 + BR1015-2, II : BR1015-1 + BR1015-2, Fimasartan + Indapamide placebo, I : BR1015-3 + BR1015-4, II : BR1015-1 + BR1015-4	Boryung Pharmaceutical Co., Ltd	Essential Hypertension	12/24	12/24